Cynthia Marsh, Registered Nurse - Home Health Medicare: Not Enrolled in Medicare Practice Location: 10 Pleasant Ct, Auburn, NH 03032 Phone: 603-451-4511 |
News Archive
Bioniche Life Sciences Inc. has provided an update on its Phase III clinical program evaluating Urocidin(TM) in the treatment of bladder cancer. On March 31st, the Company announced that recruitment had been completed in its initial Phase III registration trial evaluating Urocidin in the treatment of non-muscle-invasive bladder cancer that is refractory (unresponsive) to the current standard immunotherapy - Bacillus Calmette-Guérin (BCG).
"North Korea announced on Wednesday that it would suspend its nuclear weapons tests and uranium enrichment and allow international inspectors to monitor activities at its main nuclear complex," a move "signaling that North Korea's new leader, Kim Jong-un, is at least willing to consider a return to negotiations and to engage with the United States, which pledged in exchange to ship tons of food aid to the isolated, impoverished nation," the New York Times reports.
IRD scientist and their research partners recently identified the key role of nicotinamidase, an enzyme in the parasite Leishmania, essential for its survival but which does not exist in humans. The pathogen is incapable of developing in mammals In the absence of this enzyme. Specific targeting of this enzyme could lead to more effective ways of controlling this neglected tropical disease.
"The sour economy is producing a bumper crop of cash-strapped consumers, business owners and shady agents who're fueling a wave of insurance fraud that's keeping regulators and law enforcement officials busy from coast to coast," McClatchy reports.
Researchers in the United States have developed a new model for testing mutations in the four structural proteins of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).
› Verified 6 days ago